SCHEMBL6998719

SCHEMBL6998719

Clc1nc2ncnn2cc1-c1ccc(Br)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.38
MAPT P10636 3/20 0.38
LMNA P02545 2/20 0.38
ALDH1A1 P00352 6/20 0.38
KDM4E B2RXH2 5/20 0.38
MAPK1 P28482 2/20 0.38
AHR P35869 5/20 0.36
GAA P10253 3/20 0.36
CYP2C19 P33261 1/20 0.36
POLB P06746 1/20 0.35
HPGD P15428 3/20 0.34
NPSR1 Q6W5P4 1/20 0.34
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
TP53 P04637 1/20 0.33
HSD17B10 Q99714 1/20 0.33
DGAT1 O75907 1/20 0.33
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
CASP3 P42574 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8126943 0.70 KDM4E (0.41) SMN1; SMN2MAPTLMNAALDH1A1KDM4E
SCHEMBL22095514 0.68 LMNA (0.40) SMN1; SMN2MAPTLMNAALDH1A1AHR
SCHEMBL3677538 0.67 KDM4E (0.41) SMN1; SMN2MAPTALDH1A1KDM4EMAPK1
SCHEMBL3679921 0.65 DGAT1 (0.39) SMN1; SMN2MAPTLMNAALDH1A1KDM4E
SCHEMBL362526 0.65 KMT2A (0.40) SMN1; SMN2MAPTLMNAALDH1A1KDM4E
SCHEMBL4822430 0.63 SMN1; SMN2 (0.42) SMN1; SMN2MAPTLMNAALDH1A1KDM4E
SCHEMBL8912927 0.61 KDM4E (0.45) SMN1; SMN2MAPTALDH1A1KDM4EMAPK1
SCHEMBL28079765 0.61 MAPT (0.49) SMN1; SMN2MAPTLMNAALDH1A1KDM4E
SCHEMBL25276442 0.61 GAA (0.39) ALDH1A1KDM4EMAPK1GAACYP2C19
SCHEMBL2979196 0.61 ALDH1A1 (0.36) SMN1; SMN2MAPTALDH1A1KDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1307200-A2 SUBSTITUTED-TRIAZOLOPYRIMIDINES AS ANTICANCER AGENTS Wyeth (US) 2003-05-07 EP claimed
WO-2002002563-A2 SUBSTITUTED-TRIAZOLOPYRIMIDINES AS ANTICANCER AGENTS WYETH (US) 2002-01-10 WO claimed